Piramal Pharma Limited (PPLPHARMA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 180.91B |
| Enterprise Value | 225.42B |
| P/E Ratio | -155.44 |
| PEG Ratio | 1.47 |
| Price/Sales Ratio | 3.33 |
| Price/Book Ratio | 3.99 |
| Enterprise/Revenue | 3.87 |
| Enterprise/EBITDA | 31.38 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -0.02 |
| Operating Margin | 0.03 |
AD
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.03 |
Income Statement
| Revenue | 88.69B |
| Revenue/Share | 73.86 |
| Gross Profit | 23.83B |
| EBITDA | 9.96B |
| Net Income | -3.26B |
| Diluted EPS | -2.46 |
Balance Sheet
| Total Cash | 8.3B |
| Total Cash/Share | 6.27 |
| Total Debt | 58.73B |
| Total Debt/Equity | 0.72 |
| Current Ratio | 1.41 |
| Book Value Per Share | 61.67 |
Price History
| 52-Week Change | 26.27 |
| 52-Week High | 250.4 |
| 52-Week Low | 132.3 |
| Moving Average 50 Days | 210.95 |
| Moving Average 200 Days | 180.11 |
Statistics
| Average Volume | 6.25M |
| Shares Outstanding | 1.33B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1023:1000 |
| Last Split Date | August 02, 2023 |
AD
